Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised

Efficacy of second-line chemotherapy or immune checkpoint

Induction chemotherapy with docetaxel, cisplatin and 5

Biomedicines, Free Full-Text

Systemic Treatment Sequencing and Prediction of First-line Therapy

Induction docetaxel, cisplatin, and cetuximab followed by

Frontiers TTCC-2019-02: real-world evidence of first-line

A pilot study of camrelizumab with docetaxel and cisplatin for the

PDF] Cisplatin and fluorouracil with or without panitumumab in

Frontiers Weekly Paclitaxel, Carboplatin, and Cetuximab as First

First‐line cetuximab + platinum‐based therapy for recurrent

Full article: Cost-effectiveness of pembrolizumab for the first

First-line treatment with chemotherapy plus cetuximab in Chinese